StockNews.AISignal intelligence
Company intelligence

KVUE

Kenvue Inc. · NYSE · Consumer Defensive

Price$19.57-1.56% · −$0.31
Market cap37.59BEquity value
P / E16.6Trailing ratio
Volume11.09MLatest session
Market data

KVUE price chart

TradingView
Related signals
1 min delayed

Browse public KVUE signals with their source context and measured market impact. Open any signal for its permanent analysis page.

KVUEJul 13, 2026-3.32% since signal

Appeals Court Revives Tylenol Lawsuits; KVUE Faces Increased Legal Exposure

A federal appeals court revived hundreds of private lawsuits against Kenvue and pharmacies alleging Tylenol causes autism and ADHD. The decision heightens KVUE's legal exposure and could raise settlements, insurance costs, and reputational risk. Investors should monitor court actions, potential settlements, and any regulatory developments that could affect KVUE's profitability.

View signal analysis
Research

Company intelligence